Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease
Schreiber, S., Reinisch, W., Colombel, J.F., Sandborn, W.J., Hommes, D.W., Robinson, A.M., Huang, B., Lomax, K.G., Pollack, P.F.
Published in Journal of Crohn's and colitis (01.04.2013)
Published in Journal of Crohn's and colitis (01.04.2013)
Get full text
Journal Article
P205 - Outcome of patients with Crohn's disease and primary sclerosing cholangitis in CHARM and GAIN
Panaccione, R., Rutgeerts, P., Wolf, D., Selby, W., Russel, M., Lomax, K.G., Pollack, P.F.
Published in Journal of Crohn's and colitis (01.02.2009)
Published in Journal of Crohn's and colitis (01.02.2009)
Get full text
Journal Article
P148 - Adalimumab maintains long-term remission in patients with moderately to severely active Crohn's disease through 3 years of therapy
Panaccione, R., Colombel, J.F., Sandborn, W.J., Rutgeerts, P., D'Haens, G., Lomax, K.G., Li, J., Pollack, P.F.
Published in Journal of Crohn's and colitis (01.02.2009)
Published in Journal of Crohn's and colitis (01.02.2009)
Get full text
Journal Article
P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM
Kamm, M.A., Hanauer, S.B., Panaccione, R., Colombel, J.F., Sandborn, W.J., Lomax, K.G., Pollack, P.F.
Published in Journal of Crohn's and colitis (01.02.2009)
Published in Journal of Crohn's and colitis (01.02.2009)
Get full text
Journal Article
P137 IMPROVEMENT IN WORK PRODUCTIVITY WITH ADALIMUMAB IN CROHN'S DISEASE PATIENTS WHO FAILED PRIOR INFLIXIMAB: AN ANALYSIS OF THE CHOICE TRIAL
Lichtiger, S., Present, D.H., Persson, B., Wu, E., Kent, J.D., Lomax, K.G., Chao, J., Mulani, P.
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Get full text
Journal Article
P019 LONG-TERM FISTULA HEALING AND RESPONSE WITH ADALIMUMAB TREATMENT: 2-YEAR DATA FROM CHARM INCLUDING 1-YEAR OPEN-LABEL EXTENSION
Colombel, J.F., Kamm, M.A., Schwartz, D.A., Sandborn, W.J., Li, J., Lomax, K.G., Pollack, P.F.
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Get full text
Journal Article
P006 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE AFTER INFLIXIMAB FAILURE: 1-YEAR FOLLOW-UP OF GAIN TRIAL
Panaccione, R., Sandborn, W.J., D'Haens, G.R., Enns, R., Wolf, D.C., Lomax, K.G., Pollack, P.F.
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Get full text
Journal Article
P002 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE THROUGH 2 YEARS
Panaccione, R., Colombel, J.F., Sandborn, W.J., Rutgeerts, P., D'Haens, G.R., Lomax, K.G., Li, J., Wong, R., Pollack, P.F.
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Published in Journal of Crohn's and colitis supplements (01.02.2008)
Get full text
Journal Article